These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 37527529

  • 1. Membranous nephropathy.
    Dantas M, Silva LBB, Pontes BTM, Dos Reis MA, de Lima PSN, Moysés Neto M.
    J Bras Nefrol; 2023; 45(2):229-243. PubMed ID: 37527529
    [Abstract] [Full Text] [Related]

  • 2. Membranous nephropathy-diagnosis and identification of target antigens.
    Sethi S, Fervenza FC.
    Nephrol Dial Transplant; 2024 Mar 27; 39(4):600-606. PubMed ID: 37863839
    [Abstract] [Full Text] [Related]

  • 3. [Membranous nephropathy].
    Hanset N, Ronco P, Plaisier E.
    Rev Prat; 2021 Jan 27; 71(1):85-89. PubMed ID: 34160953
    [Abstract] [Full Text] [Related]

  • 4. Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy.
    Zhang Y, Liu Y, Liang L, Liu L, Tang X, Tang L, Chen P, Chen J, Wang Z, Cao W, Chen Q, Zhao N, Xu D.
    Kidney Blood Press Res; 2020 Jan 27; 45(5):713-726. PubMed ID: 32894840
    [Abstract] [Full Text] [Related]

  • 5. [Not Available].
    Mani LY, Huynh-Do U, Horn MP.
    Ther Umsch; 2015 Mar 27; 72(3):179-88. PubMed ID: 25722311
    [Abstract] [Full Text] [Related]

  • 6. Membranous nephropathy: integrating basic science into improved clinical management.
    Cattran DC, Brenchley PE.
    Kidney Int; 2017 Mar 27; 91(3):566-574. PubMed ID: 28065518
    [Abstract] [Full Text] [Related]

  • 7. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
    Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V.
    Nephrology (Carlton); 2015 Aug 27; 20(8):572-5. PubMed ID: 26194981
    [Abstract] [Full Text] [Related]

  • 8. Circulating antibodies to α-enolase and phospholipase A2 receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy.
    Kimura Y, Miura N, Debiec H, Morita H, Yamada H, Banno S, Ronco P, Imai H.
    Clin Exp Nephrol; 2017 Feb 27; 21(1):117-126. PubMed ID: 26830547
    [Abstract] [Full Text] [Related]

  • 9. [Membranous nephropathy: Diagnosis, new insights in pathophysiology, and therapeutic approach].
    Dahan K.
    Rev Med Interne; 2016 Oct 27; 37(10):674-679. PubMed ID: 27236434
    [Abstract] [Full Text] [Related]

  • 10. Revisiting immunological and clinical aspects of membranous nephropathy.
    Nieto-Gañán I, Iturrieta-Zuazo I, Rita C, Carrasco-Sayalero Á.
    Clin Immunol; 2022 Apr 27; 237():108976. PubMed ID: 35276323
    [Abstract] [Full Text] [Related]

  • 11. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
    Wang J, Cui Z, Lu J, Probst C, Zhang YM, Wang X, Qu Z, Wang F, Meng LQ, Cheng XY, Liu G, Debiec H, Ronco P, Zhao MH.
    Clin J Am Soc Nephrol; 2017 Oct 06; 12(10):1642-1651. PubMed ID: 28801527
    [Abstract] [Full Text] [Related]

  • 12. Membranous Nephropathy with Lambda Light Chain Restriction: A Rare Form with Serum Negative and Tissue Positive PLA2R Ab.
    Isiktas Sayilar E, Kiremitci S, Ergun I, Ensari A.
    Nephron; 2022 Oct 06; 146(4):377-380. PubMed ID: 34937026
    [Abstract] [Full Text] [Related]

  • 13. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care.
    Ronco P, Debiec H.
    Lancet; 2015 May 16; 385(9981):1983-92. PubMed ID: 26090644
    [Abstract] [Full Text] [Related]

  • 14. [Modern view on the complement system role in membranous nephropathy].
    Kamyshova ES, Semeryuk TA, Bobkova IN.
    Ter Arkh; 2022 Aug 04; 94(6):772-776. PubMed ID: 36286856
    [Abstract] [Full Text] [Related]

  • 15. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
    Chi JN, Lai TS, Wu CF, Fu TY, Chou YH, Chiu YL, Lin WC, Chiang WC, Chen YM, Wu MS.
    J Formos Med Assoc; 2019 May 04; 118(5):898-906. PubMed ID: 30639075
    [Abstract] [Full Text] [Related]

  • 16. A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis.
    Arai H, Toda N, Kamimatsuse R, Nishioka K, Endo S, Akiyama S, Maruyama S, Matsubara T, Yokoi H, Yanagita M.
    Intern Med; 2018 Oct 01; 57(19):2873-2877. PubMed ID: 29709946
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
    Bobart SA, De Vriese AS, Pawar AS, Zand L, Sethi S, Giesen C, Lieske JC, Fervenza FC.
    Kidney Int; 2019 Feb 01; 95(2):429-438. PubMed ID: 30665573
    [Abstract] [Full Text] [Related]

  • 18. [Membranous nephropathy: New insights in therapeutic approach].
    Dahan K.
    Nephrol Ther; 2017 Apr 01; 13 Suppl 1():S83-S87. PubMed ID: 28577748
    [Abstract] [Full Text] [Related]

  • 19. Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China.
    Guo N, Cao Y, Dai H, Yuan L, Shi L, Zhang Y.
    Med Sci Monit; 2019 Dec 09; 25():9364-9368. PubMed ID: 31813930
    [Abstract] [Full Text] [Related]

  • 20. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA.
    Kidney Int; 2012 Oct 09; 82(7):797-804. PubMed ID: 22673885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.